Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2025-12-25 @ 1:38 PM
NCT ID:
NCT02303392
Group ID:
EG000
Title:
Chronic Lymphocytic Leukemia (CLL)
Description:
Patients receive ibrutinib PO on days 8-28 of course 1 and on days 1-28 on subsequent courses and selinexor PO BID weekly on day 1 or bi-weekly on days 1 and 3. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Selinexor: Given PO
Ibrutinib: Given PO
Pharmacological Study: Correlative studies
Laboratory Biomarker Analysis: Correlative studies
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
16
Other Number Affected:
16
Other Number At Risk:
16
Study:
NCT02303392
Results Section:
NCT02303392
Adverse Events Module:
NCT02303392